DFG Research Centre for 'renewable therapies' to be funded for a further 4 years
The DFG Research Centre for Renewable Therapies at the Technical University of Dresden ("Renewable Therapies: From Cells to Tissues to Therapies - Engineering the Cellular Basis of Regeneration ", CRTD), following a very successful first funding period, is being extended and will be funded for a further four years. This decision was taken by the Joint Committee of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) at its meeting in Bonn on 8 October. This means that the newest of the six DFG Research Centres can continue its projects until 31 December 2013. Over this period, it will receive altogether approximately -30 million in funds.
The Dresden Research Centre was established on 1 January 2006 and has also been funded since November 2006 under the Excellence Initiative by the German federal and state governments as a cluster of excellence. The institution, in which researchers from the life sciences, natural sciences and engineering sciences collaborate, intends first of all to gain basic scientific results in regeneration and stem cell biology, and in the longer term develop these into new cellular therapies and treatment options for a wide range of diseases. The spectrum of these ranges from metabolism diseases, cancers and diseases of the immune system, as well as diseases of the heart muscle and blood vessels, via diabetes to brain and spinal cord injuries and bone tissue replacement.